Rees, Holly A.
Komor, Alexis C.
Yeh, Wei-Hsi
Caetano-Lopes, Joana
Warman, Matthew
Edge, Albert S. B.
Liu, David R.
Article History
Received: 6 February 2017
Accepted: 27 April 2017
First Online: 6 June 2017
Competing interests
: D.R.L. is a consultant and co-founder of Editas Medicine, a company that seeks to develop genome-editing therapeutics. H.A.R., A.C.K. and D.R.L. have filed patent applications on base editing. The remaining authors declare no competing financial interests.